Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Federal Sweep Nets 40 Criminal, Civil Cases For Spiked Supplements, Disease Claims

This article was originally published in The Tan Sheet

Executive Summary

A deputy assistant attorney general clarifies that ongoing investigations target “unlawful makers and marketers of dietary supplements,” but DoJ and other agencies broadly warn the entire industry about the potential for additional criminal cases as well as civil complaints.


Related Content

Supplement Sector Regulatory Milestones: Senators' Enforcement Push, GNC Supply Chain Guidelines
Naturecom Warned On GMPs After Cooperating On DMAA Recall
USPlabs' DMAA Supplement Source Convicted In Separate Criminal Case
DMAA Supplement Direct Seller Ceases Operations Under Consent Decree
GNC Supply Chain Reform Pays Dividends In DoJ Settlement From DMAA Investigation
Tracking Federal Agencies’ Enforcement In Supplement Space
Sharfstein Suggests Requiring Supplements Registration, Testing Standards
Senators Push Park Doctrine Prosecution For Spiked Supplement ‘Criminal Endeavors’
DoJ Aims To ‘Do Something About’ Crime In FDA-Regulated Industries
DMAA Product OxyElite Pro Named Potential Link In Acute Hepatitis Cases


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts